추천 제품
관련 카테고리
일반 설명
IsoStrip Mouse Monoclonal Antibody Isotyping Kit is a simple, three-step kit for the rapid characterization of mouse monoclonal antibodies.
Contents
Contents
- Development Tubes, contain lyophilized latex beads, precoated with anti-mouse-Ig antibodies
- Isotyping Strips, precoated with subclass- and light-chain-specific anti-mouse-Ig antibodies
특이성
Anti-mouse antibodies, bound to the latex beads, will react with any mouse monoclonal antibody regardless of its isotype.Goat anti-mouse antibodies, immobilized to the strip, specifically bind to each of the common mouse antibody isotypes (IgG1, IgG2a, IgG2b, IgG3, IgM, and IgA), and to the light chains.
Specificity for all specific antibodies beside IgML at 1.0 μg/ml: ≥ 2
IgM Lambda, at 1.0 μg/ml: ≥ 1
Specificity for all specific antibodies beside IgML at 1.0 μg/ml: ≥ 2
IgM Lambda, at 1.0 μg/ml: ≥ 1
애플리케이션
The kit is used for the rapid identification of class, subclass, and light-chain types of mouse monoclonal antibodies (immunoglobulins).
특징 및 장점
- Reliable: Yields comparable results to the standard ELISA assay
- Fast: 5 minutes from start to finish
- Easy: Only 3 steps
- Economical: No equipment or additional reagents required
- Highly specific: No crossreactivity with FBS
포장
1 kit containing 2 components.
규격
Assay time: 5 minutes
Sample material: Hybridoma supernatant, purified mouse monoclonal antibodies, ascites
Sample material: Hybridoma supernatant, purified mouse monoclonal antibodies, ascites
제조 메모
Working solution: Dilute Sample
- Remove the desired number of isotyping strips from the canister. Remove the caps from an equal number of development tubes.
The tubes may be labeled with a pencil or felt-tipped lab marker for easy identification. - Dilute a sample containing the mouse monoclonal antibody in 1% BSA/ phosphate-buffered saline (PBS), pH 7.2 to 7.6.
Culture supernatant samples should be diluted 1:10 to 1:100. Ascites samples should be diluted 1:20,000. These are recommended dilutions and may vary depending on the concentration of antibody in your sample. In our experience, a monoclonal antibody
concentration of 0.1 to 1 ug/ml of diluted sample gives the best results. 150 ml of this diluted sample will be added to the development tube.
기타 정보
For life science research only. Not for use in diagnostic procedures.
법적 정보
IsoStrip is a trademark of Roche
키트 구성품 전용
제품 번호
설명
- Development Tubes, containing lyophilized latex beads, precoated with anti-mouse-Ig antibodies
- Isotyping Strips, precoated with subclass- and light-chain-specific anti-mouse-Ig antibodies
Storage Class Code
11 - Combustible Solids
WGK
nwg
Flash Point (°F)
does not flash
Flash Point (°C)
does not flash
이미 열람한 고객
Wioleta M Zelek et al.
Frontiers in immunology, 11, 612402-612402 (2021-01-12)
Better understanding of roles of complement in pathology has fuelled an explosion of interest in complement-targeted therapeutics. The C5-blocking monoclonal antibody (mAb) eculizumab, the first of the new wave of complement blocking drugs, was FDA approved for treatment of Paroxysmal
Julie A Webster et al.
Cancers, 13(12) (2021-07-03)
The current endoscopy and biopsy diagnosis of esophageal adenocarcinoma (EAC) and its premalignant condition Barrett's esophagus (BE) is not cost-effective. To enable EAC screening and patient triaging for endoscopy, we developed a microfluidic lectin immunoassay, the EndoScreen Chip, which allows
Jisheng Lin et al.
Clinical and vaccine immunology : CVI, 23(8), 681-688 (2016-06-10)
There is a significant need for an effective multivalent Shigella vaccine that targets the most prevalent serotypes. Most Shigella vaccines under development utilize serotype-specific lipopolysaccharides (LPSs) as a major component based on protection and epidemiological data. As vaccine formulations advance
Wioleta M Zelek et al.
Immunology, 157(4), 283-295 (2019-05-24)
Over the last decade there has been an explosion in complement therapies; one-third of the drugs in the clinic or in development target C5 protein. Eculizumab, a monoclonal antibody (mAb) that binds C5 and blocks its cleavage by the convertase
Floriane Etienne et al.
Frontiers in oncology, 10, 20-20 (2020-03-03)
Antibodies directed against CD22 have been used in radioimmunotherapy (RIT) clinical trials to treat patients with diffuse large B-cell lymphoma (DLBCL) with promising results. However, relevant preclinical models are needed to facilitate the evaluation and optimization of new protocols. Spontaneous
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.